Cargando…
Incretin Hormones: Pathophysiological Risk Factors and Potential Targets for Type 2 Diabetes
Type 2 diabetes (T2D) is a multifaceted metabolic disorder associated with distinctive pathophysiological disturbances. One of the pathophysiological risk factors observed in T2D is dysregulation of the incretin hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1...
Autores principales: | Rosenberg, Jared, Jacob, Jordan, Desai, Priya, Park, Jeremy, Donovan, Lorin, Kim, Joon Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for the Study of Obesity
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526293/ https://www.ncbi.nlm.nih.gov/pubmed/34521773 http://dx.doi.org/10.7570/jomes21053 |
Ejemplares similares
-
Incretin hormones and type 2 diabetes
por: Nauck, Michael A., et al.
Publicado: (2023) -
The Clinical Utility of Salivary Biomarkers in the Identification of Type 2 Diabetes Risk and Metabolic Syndrome
por: Desai, Priya, et al.
Publicado: (2020) -
Incretin physiology and pathophysiology from an Asian perspective
por: Cho, Young Min
Publicado: (2015) -
Incretin hormones as immunomodulators of atherosclerosis
por: Alonso, Nuria, et al.
Publicado: (2012) -
Incretin hormones and the satiation signal
por: Holst, J J
Publicado: (2013)